Minerva Neurosciences, Inc.NERVNASDAQ
Loading
Year-over-year book value per share growth
Latest
-167.32%
↓ 334% vs avg
Percentile
P3
Near historical low
Streak
1 qtr
Consecutive declineDecelerating
Average
-38.51%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -167.32% |
| Q3 2025 | -7.70% |
| Q2 2025 | -10.16% |
| Q1 2025 | -13.45% |
| Q4 2024 | -18.56% |
| Q3 2024 | 51.29% |
| Q2 2024 | -21.60% |
| Q1 2024 | -28.57% |
| Q4 2023 | -41.96% |
| Q3 2023 | -16.66% |
| Q2 2023 | 54.46% |
| Q1 2023 | -32.93% |
| Q4 2022 | -40.56% |
| Q3 2022 | -69.95% |
| Q2 2022 | -1038.69% |
| Q1 2022 | -109.23% |
| Q4 2021 | -71.59% |
| Q3 2021 | -22.37% |
| Q2 2021 | -20.29% |
| Q1 2021 | -15.45% |
| Q4 2020 | -9.24% |
| Q3 2020 | -4.04% |
| Q2 2020 | 203.40% |
| Q1 2020 | -33.19% |
| Q4 2019 | -49.99% |
| Q3 2019 | -17.45% |
| Q2 2019 | -13.24% |
| Q1 2019 | -14.40% |
| Q4 2018 | -11.21% |
| Q3 2018 | -8.45% |
| Q2 2018 | -8.77% |
| Q1 2018 | -7.91% |
| Q4 2017 | 6.73% |
| Q3 2017 | 19.28% |
| Q2 2017 | -11.16% |
| Q1 2017 | -1.10% |
| Q4 2016 | -6.52% |
| Q3 2016 | -21.52% |
| Q2 2016 | 69.02% |
| Q1 2016 | 20.48% |